Propel Bio Management, LLC Portfolio Holdings
Propel Bio Management, LLC
- $101 Billion
- Q4 2024
Propel Bio Management, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $101 Billion distributed in 21 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Plains Gp Holdings LP with a value of $23.4B, Madrigal Pharmaceuticals, Inc. with a value of $13.3B, Akero Therapeutics, Inc. with a value of $9.56B, Achieve Life Sciences Inc with a value of $8.63B, and Applied Therapeutics Inc. with a value of $8.23B.
Examining the 13F form we can see an decrease of $71.7B in the current position value, from $172B to 101B.
Propel Bio Management, LLC is based out at Los Angeles, CA
Below you can find more details about Propel Bio Management, LLC portfolio as well as his latest detailed transactions.